相关实验视频
Updated: Jun 14, 2025

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
阿尔茨海默病中的AMPA受体:病理变化和潜在的治疗点
Luying Ning1, Rongjing Shen1, Bingqing Xie2,3
1Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China.
阿尔茨海默病涉及突触损伤,其中N-甲基-D-酸 (NMDA) 受体发挥着关键作用. 本综述侧重于α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) 受体及其作为AD治疗点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特点是突触功能障碍和认知能力下降.
- N-甲基-D-酸 (NMDA) 受体通过兴奋毒性参与AD病变发生,但记忆素提供有限的治疗益处.
- 新出现的证据强调了α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) 受体在AD相关的突触损伤和认知障碍中的重要作用.
研究的目的:
- 审查目前关于AMPA受体在阿尔茨海默病中的作用的研究.
- 阐明AMPA受体功能障碍对AD突触损伤和认知衰退的影响.
- 探索AMPA受体向药物在AD治疗中的潜力.
主要方法:
- 对阿尔茨海默病中AMPA受体的最新研究结果的文献综述.
- 对研究AMPA受体转录,表达和局部化在AD.研究的研究分析.
- 综合有关AD中AMPA受体参与的病理机制的信息.
主要成果:
- 在AMPA受体转录,表达和局部化的异常有助于AD的突触功能障碍.
- AMPA受体的改变与阿尔茨海默病患者的早期认知障碍有关.
- 目前针对NMDA受体的治疗策略在预防突触损伤方面有效性有限.
结论:
- AMPA受体是阿尔茨海默病病原和突触功能障碍的关键参与者.
- 对AMPA受体机制的进一步研究对于开发新型治疗策略至关重要.
- 向AMPA受体对未来阿尔茨海默病治疗药物开发有希望.
更多相关视频
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
相关概念视频
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...